#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hepatitis B Pancreatic neuroendocrine tumour Oropharyngeal squamous cell carcinoma Pulmonary alveolar haemorrhage Li-Fraumeni syndrome Malformation venous Oesophageal adenocarcinoma Focal segmental glomerulosclerosis Juvenile psoriatic arthritis Polymyositis Cutaneous T-cell lymphoma stage I Krabbe's disease Neuronal ceroid lipofuscinosis Osteosarcoma recurrent Cataract More trials…

    Learn about Rare Diseases

    VEXAS syndrome – Treatment Factor IX deficiency – Treatment X-linked lymphoproliferative syndrome – Life with Disease IgA nephropathy – Diagnostics Antisynthetase syndrome – Life with Disease Testicular leiomyosarcoma – Basic Information Congenital hypotransferrinaemia – Diagnostics Angiosarcoma – Trials in Disease Osteosarcoma recurrent – Basic Information Sjogren’s syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Secukinumab Olopatadine FLUCLOXACILLIN SODIUM PEGZILARGINASE Sodium Gluconate POTASSIUM CLAVULANATE IDOR-1117-2520C Cladribine Doxribtimine Guanfacine Pamiparib Tusamitamab Ravtansine Plerixafor Auto4 Sasanlimab Tegafur Alrefimotide Diltiazem Hydrochloride Abc-24F-116 [18F]DED More therapies…

    Learn about Your Condition

    Procedural pain Agitation Asplenia Oxygen saturation Renal injury Vulvovaginal discomfort Postprandial hypoglycaemia Rectal cancer stage II Radiation skin injury Ophthalmoplegia Knee arthroplasty Biotinidase deficiency Allergic respiratory disease Ureteric cancer Hypothyroidism More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Musculoskeletal Diseases

  • Study on the Effects of Risankizumab in Patients with Very Early Axial Spondyloarthritis

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Axial spondyloarthritis
    Investigated Drugs:
    • Risankizumab
    Germany

  • Study on the Safety and Efficacy of Delandistrogene Moxeparvovec and Imlifidase for Patients with Duchenne Muscular Dystrophy with Pre-existing Antibodies

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Imlifidase
    • Delandistrogene Moxeparvovec
    Spain

  • Study Comparing Diclofenac and Thiocolchicoside Injection to Diclofenac Alone for Patients with Acute Moderate to Severe Low Back Pain

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Back pain
    Investigated Drugs:
    • Diclofenac Sodium
    • Thiocolchicoside
    Greece

  • Study on Peripheral Spondyloarthritis: Comparing Methotrexate Disodium and Golimumab for Early Remission in Adult Patients

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Peripheral spondyloarthritis
    Investigated Drugs:
    • Golimumab
    • Methotrexate Disodium
    Belgium

  • Study on the Effectiveness of Collagenase, Percutaneous Needle Fasciotomy, and Limited Fasciectomy for Patients with Mild or Moderate Dupuytren’s Contracture

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Dupuytren’s contracture
    Investigated Drugs:
    • Collagenase
    Finland

  • Study on Spironolactone for Treating Active Rheumatoid Arthritis in Patients

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Spironolactone
    France Germany
Previous Page
1 … 45 46 47 48 49 … 67
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!